ConductScience.org, home

Paper27353164

Antibiotics in the clinical pipeline at the end of 2015.

Butler MS and 2 others. J Antibiot (Tokyo), 2017. Cited by 236 papers, by iCite.

Cite this record

ConductScience Library. Antibiotics in the clinical pipeline at the end of 2015. Papers, record 27353164. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27353164

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibiotics in the clinical pipeline at the end of 2015.
PubMed
Journal
J Antibiot (Tokyo)
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
236
iCite
Relative citation ratio, by iCite
11.4
iCite
Revised in PubMed
2026-10-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Butler MSMark S
2Blaskovich MAMark At
3Cooper MAMatthew A

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
BacteriaMajor topic
Drug DesignMajor topic
Animals
Drug Discovery
Drug Resistance, Multiple, Bacterial
Humans
Microbial Sensitivity Tests

Source PubMed

Download CSV of topics

References216

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112234833Discovery of a novel and potent class of FabI-directed antibacterial agents.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12234833PubMed
221732630A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption.J Med Chem2011https://conductscience.org/library/papers/21732630PubMed
325993059
Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.
J Med Chem2015https://conductscience.org/library/papers/25993059PubMed
424295985In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24295985PubMed
523318809Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23318809PubMed
626349824Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26349824PubMed
726230280Development of new antibiotics: taking off finally?Swiss Med Wkly2015https://conductscience.org/library/papers/26230280PubMed
823422913Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infections.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23422913PubMed
920112168The pleuromutilin antibiotics: a new class for human use.Curr Opin Investig Drugs2010https://conductscience.org/library/papers/20112168PubMed
1020030476A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.Pharmacotherapy2010https://conductscience.org/library/papers/20030476PubMed
1124002361Antibiotics in the clinical pipeline in 2013.J Antibiot (Tokyo)2013https://conductscience.org/library/papers/24002361PubMed
1211864945In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.J Antimicrob Chemother2002https://conductscience.org/library/papers/11864945PubMed
138452346In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8452346PubMed
1420167788Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa.Science2010https://conductscience.org/library/papers/20167788PubMed
1523433442Activity of AFN-1252, a novel FabI inhibitor, against Staphylococcus aureus in an in vitro pharmacodynamic model simulating human pharmacokinetics.J Chemother2013https://conductscience.org/library/papers/23433442PubMed
1620426497New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.Drugs2010https://conductscience.org/library/papers/20426497PubMed
1722431851Oritavancin: mechanism of action.Clin Infect Dis2012https://conductscience.org/library/papers/22431851PubMed
1826645269In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria.J Antimicrob Chemother2016https://conductscience.org/library/papers/26645269PubMed
1926085253Mining the microbial dark matter.Nature2015https://conductscience.org/library/papers/26085253PubMed
2025404020Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.Drugs2015https://conductscience.org/library/papers/25404020PubMed

See all 216 referencesDownload CSV of references

Cited by135

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 236 citations.

PMIDTitleJournalYearIn PapersSource
42890137High-throughput screening to identify inhibitors of the MTB CARD•RNA polymerase protein-protein interaction.Front Tuberc2026https://conductscience.org/library/papers/42890137PubMed
42032263Stepwise antibacterial strategy for orthopedic implants using bacteriophages on electrospun cefiderocol/PCl/Gt nanofibers over PEO-coated Mg3ZnCa.NPJ Biomed Innov2025https://conductscience.org/library/papers/42032263PubMed
41923587Recent trends in dual-acting hybrid antibiotics and combination therapies against Gram-negative pathogens.J Microbiol2026https://conductscience.org/library/papers/41923587PubMed
41654958
Verification and application of an automated real-time antimicrobial susceptibility testing system: for accelerated antibiotic susceptibility testing and high-throughput screening of antibiotic synergistic effects.
J Biol Eng2026https://conductscience.org/library/papers/41654958PubMed
40978463Synthesis and biological activity evaluation of a novel pleuromutilin derivative 22-((2-methyl-1-(1H-pyrrole-2-carboxamido)propan-2-yl)thio)-deoxypleuromutilin.Front Pharmacol2025https://conductscience.org/library/papers/40978463PubMed
40679465Engineering Streptomyces coelicolor for heterologous expression of the thiopeptide GE2270A-A cautionary tale.J Ind Microbiol Biotechnol2024https://conductscience.org/library/papers/40679465PubMed
40558176Challenges of Carbapenem-Resistant Enterobacteriaceae in the Development of New β-Lactamase Inhibitors and Antibiotics.Antibiotics (Basel)2025https://conductscience.org/library/papers/40558176PubMed
40447846Antibiotics re-booted-time to kick back against drug resistance.NPJ Antimicrob Resist2025https://conductscience.org/library/papers/40447846PubMed
40295486An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens.Nat Commun2025https://conductscience.org/library/papers/40295486PubMed
40189806Design and Production of Geranylated Cyclic Peptides by the RiPP Enzymes SyncM and PirF.Biomacromolecules2025https://conductscience.org/library/papers/40189806PubMed
39740123Intracellular Quantification of an Antibiotic Metal Complex in Single Cells of Escherichia coli Using Cryo-X-ray Fluorescence Nanoimaging.ACS Nano2025https://conductscience.org/library/papers/39740123PubMed
39676054Fragment Discovery by X-Ray Crystallographic Screening Targeting the CTP Binding Site of Pseudomonas Aeruginosa IspD.Angew Chem Int Ed Engl2025https://conductscience.org/library/papers/39676054PubMed
39248524High-throughput screening identification of apigenin that reverses the colistin resistance of mcr-1-positive pathogens.Microbiol Spectr2024https://conductscience.org/library/papers/39248524PubMed
39207823Whole Cell Luminescence-Based Screen for Inhibitors of the Bacterial Sec Machinery.Biochemistry2024https://conductscience.org/library/papers/39207823PubMed
38855277Community-acquired pneumonia: The importance of the early detection of drug-resistant organisms.World J Crit Care Med2024https://conductscience.org/library/papers/38855277PubMed
38683490Application of 18β-glycyrrhetinic acid in the structural modification of natural products: a review.Mol Divers2025https://conductscience.org/library/papers/38683490PubMed
38633581Photodynamic Therapy of LD4-Photosensitizer Attenuates the Acute Pneumonia Induced by Klebsiella pneumoniae.ACS Pharmacol Transl Sci2024https://conductscience.org/library/papers/38633581PubMed
386118444-[(E)-2-(1-Pyrenyl)Vinyl]Pyridine Complexes: How to Modulate the Toxicity of Heavy Metal Ions to Target Microbial Infections.Molecules2024https://conductscience.org/library/papers/38611844PubMed
38396594An Evaluation of the Impact of an OPEN Stewardship Generated Feedback Intervention on Antibiotic Prescribing among Primary Care Veterinarians in Canada and Israel.Animals (Basel)2024https://conductscience.org/library/papers/38396594PubMed
38115687Application of Antimicrobial Peptides as Diagnostic Biosensors.Anal Chem2024https://conductscience.org/library/papers/38115687PubMed

See all 135 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27353164

GET https://conductscience.org/api/papers/v1/27353164/references?page=2